Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by consultant99on Oct 27, 2022 12:51am
332 Views
Post# 35052084

RE:RE:RE:What happened in last 15 minutes

RE:RE:RE:What happened in last 15 minutesThe previous PP paperwork was due well before the money. I expect that the money owed for this PP is due October 31st and to raise the money through a sale of existing shares  requires a coupe of days to clear the exchange and be deposited in time to be wired to the company.

Long story short todays sell off sure feels like a last ditch effort to raise money to pay for one or more participants in the 2nd PP. 

I think existing shareholders need to see a steady rise in the share price going forward. The PPs have sucked all of the upward momentum out of the share price for the last two months. The company needs to start being more forthright around things like when the 25th patient is finished being scanned and when they apply for BTD. 

With money to fund the company for the next year now is the perfect opportunity to start building expectations and upward price momentum as we get closer to the BTD approval AA and the results of the Covid vaccine animal tests. 
<< Previous
Bullboard Posts
Next >>